Antiangiogenic cancer therapy

Seminars in Cancer Biology

Volumn 14, Issue 2, 2004, Pages 139-145

  Cao, Yihai ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Angiogenesis; Metastasis; Neovascularization; Therapy; Tumor

Indexed keywords

2 (8 HYDROXY 6 METHOXY 1 OXO 1H 2 BENZOPYRAN 3 YL)PROPIONIC ACID; 2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 5,6,7,13 TETRAHYDRO 12 (3 HYDROXYPROPYL) 9 ISOPROPOXYMETHYLINDENO[2,1 A]PYRROLO[3,4 C]CARBAZOL 5(12H) ONE DIMETHYLGLYCINE ESTER; AE 941; ANGIOGENESIS INHIBITOR; AVASTATIN; CATECHIN; FLAVONOID; FLAVOPIRIDOL; PD 547; POLYPHENOL; QUERCETIN; RESVERATROL; SEMAXANIB; SU 11284; SUL 1284; UNCLASSIFIED DRUG; VANDETANIB; VASCULOTROPIN INHIBITOR; VATALANIB;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLOOD VESSEL; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; CELL STRUCTURE; CLINICAL TRIAL; DISEASE MODEL; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; MOLECULAR MECHANICS; NONHUMAN; REVIEW; TUMOR VASCULARIZATION;

EID: 1242340428     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2003.09.018     Document Type: Review

References (41)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186.
2. Gimbrone M.A. Jr., Cotran R.S., Leapman S.B., Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst. 52:1974;413-427.
3. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L.et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7:2001;1194-1201.
4. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20:2002;4368-4380.
5. McDonald D.M., Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 62:2002;5381-5385.
6. Folberg R., Hendrix M.J., Maniotis A.J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol. 156:2000;361-381.
7. Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M., Pe'er J. et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155:1999;739-752.
8. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S.et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156:2000;1363-1380.
9. Jain R.K. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin. Oncol. 29:2002;3-9.
10. Cao Y., Linden P., Farnebo J., Cao R., Eriksson A., Kumar V.et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14389-14394.
11. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer. 2:2002;795-803.
12. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S.et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:1993;841-844.
13. Garber K. Angiogenesis inhibitors suffer new setback. Nat. Biotechnol. 20:2002;1067-1068.
14. Makino Y., Cao R., Svensson K., Bertilsson G., Asman M., Tanaka H.et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature. 414:2001;550-554.
15. Niethammer A.G., Xiang R., Becker J.C., Wodrich H., Pertl U., Karsten G.et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat. Med. 8:2002;1369-1375.
16. Relf M., LeJeune S., Scott P.A., Fox S., Smith K., Leek R.et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57:1997;963-969.
17. Folkman J. Looking for a good endothelial address. Cancer Cell. 1:2002;113-115.
18. Inoue M., Hager J.H., Ferrara N., Gerber H.P., Hanahan D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell. 1:2002;193-202.
19. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
20. Cao Y., O'Reilly M.S., Marshall B., Flynn E., Ji R.W., Folkman J. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101:1998;1055-1063.
21. Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int. J. Biochem. Cell Biol. 33:2001;357-369.
22. Cao Y. Endogenous angiogenesis inhibitors: angiostatin, endostatin, and other proteolytic fragments. Prog. Mol. Subcell. Biol. 20:1998;161-176.
23. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:1994;315-328.
24. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S.et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.
25. Cao Y., Ji R.W., Davidson D., Schaller J., Marti D., Sohndel S.et al. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271:1996;29461-29467.
26. Mulichak A.M., Tulinsky A., Ravichandran K.G. Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution. Biochemistry. 30:1991;10576-10588.
27. Rejante M.R., Byeon I.J., Llinas M. Ligand specificity of human plasminogen kringle 4. Biochemistry. 30:1991;11081-11092.
28. Cao Y., Chen A., An S.S., Ji R.W., Davidson D., Llinas M. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272:1997;22924-22928.
29. Cao R., Wu H.L., Veitonmaki N., Linden P., Farnebo J., Shi G.Y.et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5728-5733.
30. Li F., Yang J., Liu X., He P., Ji S., Wang J.et al. Human glioma cell BT325 expresses a proteinase that converts human plasminogen to kringle 1-5-containing fragments. Biochem. Biophys. Res. Commun. 278:2000;821-825.
31. Claesson-Welsh L., Welsh M., Ito N., Anand-Apte B., Soker S., Zetter B. et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5579-5583.
32. Dong Z., Kumar R., Yang X., Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 88:1997;801-810.
33. Moser T.L., Stack M.S., Asplin I., Enghild J.J., Hojrup P., Everitt L.et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2811-2816.
34. Ramchandran R., Dhanabal M., Volk R., Waterman M.J., Segal M., Lu H.et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 255:1999;735-739.
35. Troyanovsky B., Levchenko T., Mansson G., Matvijenko O., Holmgren L. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J. Cell Biol. 152:2001;1247-1254.
36. Moser T.L., Kenan D.J., Ashley T.A., Roy J.A., Goodman M.D., Misra U.K. et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6656-6661.
37. Griscelli F., Li H., Bennaceur-Griscelli A., Soria J., Opolon P., Soria C.et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6367-6372.
38. Lu H., Dhanabal M., Volk R., Waterman M.J., Ramchandran R., Knebelmann B.et al. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells. Biochem. Biophys. Res. Commun. 258:1999;668-673.
39. Lucas R., Holmgren L., Garcia I., Jimenez B., Mandriota S.J., Borlat F. et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood. 92:1998;4730-4741.
40. Cao Y., Cao R. Angiogenesis inhibited by drinking tea. Nature. 398:1999;381.
41. Cao Y., Cao R., Brakenhielm E. Antiangiogenic mechanisms of diet-derived polyphenols. J. Nutr. Biochem. 13:2002;380-390.